NASDAQ

Radiopharm Theranostics Limited - American Depositary Shares (RADX)

592 Thanks from members

Radiopharm Theranostics Limited (RADX) exhibits strong clinical momentum across its radiopharmaceutical pipeline, including Phase 1/2a trials and upcoming FDA meetings, countered by severe cash burn and a proposed multi-component capital raise.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →